Philips announced today that it plans to repurchase up to 6 million shares of stock as part of long-term incentive plans. The company said the repurchase covers certain obligations arising from its incentive plans. At the current share price, the shares represent an amount of up to approximately $142.2 million (€125 million). This repurchase marks […]
Funding Roundup
A commodities blockchain company is using BioSig to go public
BioSig (Nasdaq: BSGM) has merged with Streamex Exchange Corp. in a move that will take the British Columbia–based commodities tokenization business public. The companies on May 23 announced the signing of a definitive agreement, followed by a May 28 news release about the successful closing of the share exchange transaction. The move comes more than […]
Neuralink value reportedly eclipses $9B with $600M raise
Semafor reports that Neuralink raised another $600 million in a deal that values the company at $9 billion before the infusion of funds. The report cites people with knowledge of the matter saying that the Elon Musk-backed brain-computer interface (BCI) venture brought in $600 million. This report comes about a month after a report that […]
Samsung eyes stake in Exo Imaging
Samsung Electronics‘ investment arm is in discussions to join a group of firms backing software and medical device company Exo Imaging, according to a Bloomberg report. The private fundraising round, led by Sands Capital, Bold Capital and Qubit Health Capital, could total about $100 million, Bloomberg reports. Santa Clara, California-based Exo develops handheld ultrasound devices […]
Salvia BioElectronics raises $60M for migraine therapy implant
Salvia BioElectronics announced today that it completed a $60 million Series B financing round to support its migraine treatment. The funding enables the Dutch medtech company to complete the clinical development and prepare for the launch of its MySalvia Therapy. This proprietary neuromodulation technology utilizes an ultra-thin implant to target key nerves involved in migraine. […]
Surgify Medical raises $7.8M Series A to support bone-cutting tech
Surgify Medical announced today that it raised $7.8 million (€7 million) in a Series A financing round. Helsinki, Finland-based Surgify plans to use the investment to advance its bone surgery technology. The company designs the Halo device for bone cutting in surgical procedures. According to a news release, conventional surgical drills can bring risks if […]
EBR Systems raises $36.1M for leadless pacing tech
EBR Systems announced that it received commitments for a fully underwritten institutional placement to raise $36.1 million (A$55.9 million). In addition to the committed funding, the company plans to undertake a non-underwritten security purchase plan. Eligible securityholders of EBR could contribute to an additional $3.9 million (A$6 million) in funding. The Australia-based company plans to […]
Globus Medical announces $500M share repurchase program
Globus Medical (NYSE:GMED) announced that its board of directors authorized a share repurchase program totaling up to $500 million. The repurchase includes the Audobon, Pennsylvania-based orthopedic device company’s outstanding common stock. Globus says the timing and actual number of shares repurchased will be determined by management at its discretion. Additionally, the timing and number of […]
Senseonics opens $50M public offering, $25M private placement with Abbott
Senseonics (NYSE:SENS) is set to bring in $75 million through a public offering and a private placement with a fellow CGM maker. Our sister site, Drug Delivery Business News, reports today that the company is offering $50 million in its public offering, with another $25 million set to come through a private placement agreement with Abbott. […]
Philips prices $1.1B offering to pay off debt, finance green projects
Philips announced today that it priced offerings of fixed-rate notes worth $1.1 billion (€1 billion) in proceeds. The company priced an offering of €500 million fixed-rate notes due 2030 and €500 million fixed-rate notes due 2035. They fall under its European Medium Term Note EMTN Program. Philips plans to use proceeds for general corporate purposes […]
Alpheus Medical raises $52M for ultrasound-activated tumor therapy
Alpheus Medical announced today that it closed an oversubscribed Series B financing round, bringing in $52 million. The Chanhassen, Minnesota–based solid body cancer treatment developer plans to use funds to support a phase 2B randomized controlled trial. The study evaluates the efficacy of its sonodynamic therapy (SDT) for treating newly diagnosed glioblastoma. HealthQuest Capital and […]
